Yes, diabetes is associated with a higher risk of developing Alzheimer's disease. That does not mean diabetes directly causes Alzheimer's or that everyone with diabetes will develop dementia. Dementia is a decline in memory and other thinking abilities that interferes with daily life. The evidence points to a meaningful population-level risk increase, with vascular damage likely playing an important role.
Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.
Table of Contents
- How much does diabetes raise the risk?
- Why might diabetes affect the brain?
- Does diabetes cause Alzheimer's disease?
- Can tighter glucose control or medication prevent dementia?
- When should cognitive screening become part of care?
How much does diabetes raise the risk?
The American diabetes Association's 2025 evidence review found that diabetes was associated with a 43% higher risk of Alzheimer dementia. It was also associated with a 91% higher risk of vascular dementia, which results from impaired blood flow or blood-vessel damage in the brain. The ADA evidence review included 122 prospective observational studies. A separate meta-analysis covered 17 long-term population studies and 1,746,777 people.
It found a 53% higher incidence of Alzheimer's disease among people with diabetes. The 2017 Diabetes Research and Clinical Practice analysis reported a relative risk of 1.53. These are relative increases between groups, not personal predictions. A 43% higher relative risk does not mean that a person with diabetes has a 43% chance of developing Alzheimer's.
Why might diabetes affect the brain?
Diabetes may contribute to dementia by damaging blood vessels. This damage can reduce the delivery of oxygen and nutrients to brain tissue. The National Institute on Aging identifies diabetes as a vascular problem that can compound brain damage and increase vascular-dementia risk.
Its explanation of brain and vascular changes helps explain why the association with vascular dementia is stronger than the association with Alzheimer dementia. Vascular injury may therefore account for part of the diabetes–dementia connection. The available evidence does not show that it explains the entire association with Alzheimer's disease.
Does diabetes cause Alzheimer's disease?
The research shows an association, not direct causation. Most risk estimates come from observational studies, which follow people over time but do not assign them to have diabetes or not. These studies cannot fully separate diabetes from factors that may occur alongside it, including age, obesity, inactivity, high blood pressure, and vascular disease.
Any of these factors could contribute to the observed difference in dementia risk. The findings are still useful: they identify people with diabetes as a group that warrants attention to cognitive and vascular health. They cannot predict whether a particular person will develop Alzheimer's or when it might happen.
Can tighter glucose control or medication prevent dementia?
Higher A1C—a measure of average blood glucose—is associated with lower cognitive function in people with diabetes. However, analyses from the ACCORD, ADVANCE, and VADT trials found no cognitive advantage from intensive glucose-lowering targets compared with standard control, according to the ADA evidence review. Medication evidence is also unsettled.
A 2024 analysis in Alzheimer's Research & Therapy found lower dementia associations for several diabetes drugs in observational studies, but 23 randomized trials found dementia risks comparable with placebo or other treatments. No diabetes drug has therefore been shown by this evidence to prevent dementia. People should not intensify glucose targets or switch medication solely for dementia prevention without discussing the decision with their diabetes clinician.
When should cognitive screening become part of care?
The ADA recommends screening older adults with diabetes at least annually for geriatric syndromes, including cognitive impairment. The 2026 Standards of Care for older adults emphasize this because cognitive decline can make diabetes self-management less safe and increase caregiver needs. Practical steps include:.
- Ask whether cognitive screening is included in the annual diabetes review.
- Report new trouble remembering doses, following glucose-monitoring steps, or keeping appointments.
- Ask for a medication and safety review if memory or judgment begins affecting diabetes care.
- Discuss whether a trusted caregiver should help with medications, appointments, or monitoring.
